Encoded Therapeutics
PrivateLast Round
Series D
Jul 22, 2020
Total Funding Raised
$239.1M
Company Overview
Encoded Therapeutics is a biotechnology company developing precision genetic medicines for severe neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Encoded Therapeutics Comparables
Compare Encoded Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stoke Therapeutics, Inc. | 84% | |
| Harmony Biosciences Holdings, Inc. | 76% | |
| Takeda | 70% | |
Encoded Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 22, 2020 | ||||
| Series C | Jun 26, 2019 | ||||
| Seed | Apr 18, 2017 | ||||
| Accelerator | Jul 30, 2015 | ||||
| Accelerator | Oct 15, 2014 |
Key People
Founding team and executive leadership
Encoded Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SoftBank Investment Advisers | Series D |
| Farallon Capital Management | Series D |
| Boxer Capital | Series C, Series D |
| GV | Series D |
| Altitude Life Science Ventures | Series C, Seed |
| ARCH Venture Partners | Series C, Seed, Series D |
| SoftBank Group | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 6, 2026
Developing ETX101, a gene therapy for Dravet syndrome, preparing for BLA submission.
- Jul 22, 2020
$135M round led by GV
Encoded Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Encoded Therapeutics's valuation, stock price, and market status.